Prostaglandins compromise basal forebrain cholinergic neuron differentiation and survival: Action at EP1/3 receptors results in AIF-induced death

Brain Research

Volumn 1285, Issue , 2009, Pages 30-41

  Jonakait, G Miller ^a,b   Ni, Li ^a,b  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Apoptosis inducing factor; Autism; Choline acetyltransferase; Cholinergic; PGE2; Prostaglandin

Indexed keywords

APOPTOSIS INDUCING FACTOR; BISBENZIMIDE; BUCLADESINE; BUTAPROST; CASPASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; IBUPROFEN; MISOPROSTOL; PROSTAGLANDIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN EP1 RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR; SULPROSTONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; FOREBRAIN; IN VITRO STUDY; MICROGLIA; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE FIBER GROWTH; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ANIMALS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BASAL NUCLEUS OF MEYNERT; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DINOPROSTONE; ENCEPHALITIS; MICROGLIA; NEURONS; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E;

RATTUS;

EID: 67651180517     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.037     Document Type: Article

References (87)

1. Abramovitz M., Adam M., Boie Y., Carriere M., Denis D., Godbout C., Lamontagne S., Rochette C., Sawyer N., Tremblay N.M., Belley M., Gallant M., Dufresne C., Gareau Y., Ruel R., Juteau H., Labelle M., Ouimet N., and Metters K.M. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483 (2000) 285-293
2. Ahmad A.S., Ahmad M., Brum-Fernandes A.J., and Dore S. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res. 1066 (2005) 71-77
3. Ahmad A.S., Zhuang H., Echeverria V., and Dore S. Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity. J. Neurotrauma 23 (2006) 1895-1903
4. Ajmone-Cat M.A., Nicolini A., and Minghetti L. Prolonged exposure of microglia to lipopolysaccharide modified the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. J. Neurochem. 87 (2003) 1193-1203
5. Akaike A., Kaneko S., Tamura Y., Nakata N., Shiomi H., Ushikubi F., and Narumiya S. Prostaglandin E2 protects cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 663 (1994) 237-243
6. Aloisi F., Penna G., Cerase J., Iglesias B.M., and Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159 (1997) 1604-1612
7. Aloisi F., De Simone R., Columba-Cabezas S., and Levi G. Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. J. Neurosci. Res. 56 (1999) 571-580
8. Andreasson K.I., Savonenko A., Vidensky S., Goellner J.J., Zhang Y., Shaffer A., Kaufmann W.E., Worley P.F., Isakson P., and Markowska A.L. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J. Neurosci. 21 (2001) 8198-8209
9. Aoki J., Katoh H., Yasui H., Yamaguchi Y., Nakamura K., Hasegawa H., Ichikawa A., and Negishi M. Signal transduction pathway regulating prostaglandin EP3 receptor-induced neurite retraction: requirement for two different tyrosine kinases. Biochem. J. 340 Pt 2 (1999) 365-369
10. Bauer M.K., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P.J., Bauer J., and Fiebich B.L. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 243 (1997) 726-731
11. Caggiano A.O., and Kraig R.P. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72 (1999) 565-575
12. Cao G., Clark R.S., Pei W., Yin W., Zhang F., Sun F.Y., Graham S.H., and Chen J. Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation. J Cereb. Blood Flow Metab. 23 (2003) 1137-1150
13. Carlson N.G. Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid. J. Neurosci. Res. 71 (2003) 79-88
14. Cazevieille C., Muller A., Meynier F., Dutrait N., and Bonne C. Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem. Int. 24 (1994) 395-398
15. Chen J., Marsh T., Zhang J.S., and Graham S.H. Expression of cyclo-oxygenase 2 in rat brain following kainate treatment. NeuroReport 6 (1995) 245-248
16. Collaco-Moraes Y., Aspey B., Harrison M., and de Belleroche J. Cyclo-oxygenase-2 messenger RNA induction in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16 (1996) 1366-1372
17. Cregan S.P., Fortin A., MacLaurin J.G., Callaghan S.M., Cecconi F., Yu S.W., Dawson T.M., Dawson V.L., Park D.S., Kroemer G., and Slack R.S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 158 (2002) 507-517
18. Dore S., Otsuka T., Mito T., Sugo N., Hand T., Wu L., Hurn P.D., Traystman R.J., and Andreasson K. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann. Neurol. 54 (2003) 155-162
19. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., and Rothstein J.D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52 (2002) 771-778
20. Dumont I., Peri K.G., Hardy P., Hou X., Martinez-Bermudez A.K., Molotchnikoff S., Varma D.R., and Chemtob S. PGE2, via EP3 receptors, regulates brain nitric oxide synthase in the perinatal period. Am. J. Physiol. 275 (1998) R1812-R1821
21. Echeverria V., Clerman A., and Dore S. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure. Eur. J. Neurosci. 22 (2005) 2199-2206
22. Feng Z.H., Wang T.G., Li D.D., Fung P., Wilson B.C., Liu B., Ali S.F., Langenbach R., and Hong J.S. Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci. Lett. 329 (2002) 354-358
23. Fiebich B.L., Lieb K., Kammerer N., and Hull M. Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia. J. Neurochem. 86 (2003) 173-178
24. Fonfria E., Dare E., Benelli M., Sunol C., and Ceccatelli S. Translocation of apoptosis-inducing factor in cerebellar granule cells exposed to neurotoxic agents inducing oxidative stress. Eur. J. Neurosci. 16 (2002) 2013-2016
25. Fonnum F. Rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24 (1975) 403-407
26. Goldin E., Harel S., Tomer A., and Yavin E. Thromboxane and prostacyclin levels in fetal rabbit brain and placenta after intrauterine partial ischemic episodes. J. Neurochem. 54 (1990) 587-591
27. Hagberg H., and Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr. Opin. Neurol. 18 (2005) 117-123
28. Hewett S.J., Uliasz T.F., Vidwans A.S., and Hewett J.A. Cyclooxygenase-2 contributes to N-methyl-d-aspartate-mediated neuronal cell death in primary cortical cell culture. J. Pharmacol. Exp. Ther. 293 (2000) 417-425
29. Hillock C.J., and Crankshaw D.J. Inhibitory prostanoid EP receptors in human non-pregnant myometrium. Eur. J. Pharmacol. 378 (1999) 99-108
30. Hirst W.D., Young K.A., Newton R., Allport V.C., Marriott D.R., and Wilkin G.P. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell. Neurosci. 13 (1999) 57-68
31. Ho L., Purohit D., Haroutunian V., Luterman J.D., Willis F., Naslund J., Buxbaum J.D., Mohs R.C., Aisen P.S., and Pasinetti G.M. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch. Neurol. 58 (2001) 487-492
32. Hoozemans J.J., Rozemuller A.J., Janssen I., de Groot C.J., Veerhuis R., and Eikelenboom P. Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol. (Berl) 101 (2001) 2-8
33. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S., and Ross M.E. Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1294-1299
34. Ishihara O., Khan H., Sullivan M.H., and Elder M.G. Interleukin-1 beta stimulates decidual stromal cell cyclo-oxygenase enzyme and prostaglandin production. Prostaglandins. 44 (1992) 43-52
35. Jonakait G.M. The effects of maternal inflammation on neuronal development: possible mechanisms. Int. J. Dev. Neurosci. 25 (2007) 415-425
36. Jonakait G.M., Luskin M.B., Wei R., Tian X.-F., and Ni L. Conditioned medium from activated microglia promotes cholinergic differentiation in the basal forebrain in vitro. Dev. Biol. 177 (1996) 85-95
37. Jonakait G.M., Wen Y., Wan Y., and Ni L. Macrophage cell-conditioned medium promotes cholinergic differentiation of undifferentiated progenitors and synergizes with nerve growth factor action in the developing basal forebrain. Exp. Neurol. (1999) 1-13
38. Kaeser F., Luthy C., Herschkowitz N., and Oetliker O. The effect of temporary hypoxia on prostaglandin synthesis in mouse brain cell cultures during development. Prostaglandins Leukot. Essent. Fatty Acids 32 (1988) 75-81
39. Katoh H., Negishi M., and Ichikawa A. Prostaglandin E receptor EP3 subtype induces neurite retraction via small GTPase Rho. J. Biol. Chem. 271 (1996) 29780-29784
40. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., Kunz A., Cho S., Orio M., and Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 12 (2006) 225-229
41. Kelley K.A., Ho L., Winger D., Freire-Moar J., Borelli C.B., Aisen P.S., and Pasinetti G.M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol. 155 (1999) 995-1004
42. Kim E.J., Lee J.E., Kwon K.J., Lee S.H., Moon C.H., and Baik E.J. Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures. Brain Res. 908 (2001) 1-9
43. Kim E.J., Kwon K.J., Park J.Y., Lee S.H., Moon C.H., and Baik E.J. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J. Neurosci. Res. 70 (2002) 97-107
44. Kitanaka J., Hashimoto H., Gotoh M., Kondo K., Sakata K., Hirasawa Y., Sawada M., Suzumura A., Marunouchi T., Matsuda T., and Baba A. Expression pattern of messenger RNAs for prostanoid receptors in glial cell cultures. Brain Res. 707 (1996) 282-287
45. Levi G., Minghetti L., and Aloisi F. Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 80 (1998) 899-904
46. Liu D., Wu L., Breyer R., Mattson M.P., and Andreasson K. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann. Neurol. 57 (2005) 758-761
47. Martinez H.J., Dreyfus C.F., Jonakait G.M., and Black I.B. Nerve growth factor selectively increases cholinergic markers but not neuropeptides in rat basal forebrain in culture. Brain Res. 412 (1987) 295-301
48. McCullough L., Wu L., Haughey N., Liang X., Hand T., Wang Q., Breyer R.M., and Andreasson K. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J. Neurosci. 24 (2004) 257-268
49. Meisdalen K., Dajani O.F., Christoffersen T., and Sandnes D. Prostaglandins enhance epidermal growth factor-induced DNA synthesis in hepatocytes by stimulation of E prostanoid 3 and F prostanoid receptors. J. Pharmacol. Exp. Ther. 322 (2007) 1044-1050
50. Miettinen S., Fusco F.R., Yrjanheikki J., Keinanen R., Hirvonen T., Roivainen R., Narhi M., Hokfelt T., and Koistinaho J. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6500-6505
51. Minghetti L., Nicolini A., Polazzi E., Creminon C., Maclouf J., and Levi G. Prostaglandin E2 downregulates inducible nitric oxide synthase expression in microglia by increasing cAMP levels. Adv. Exp. Med. Biol. 433 (1997) 181-184
52. Minghetti L., Nicolini A., Polazzi E., Creminon C., Maclouf J., and Levi G. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19 (2003) 152-160
53. Mirjany M., Ho L., and Pasinetti G.M. Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J. Pharmacol. Exp. Ther. 301 (2002) 494-500
54. Mitchell M.D., Dudley D.J., Edwin S.S., and Schiller S.L. Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells. Eur. J. Pharmacol. 192 (1991) 189-191
55. Molina-Holgado E., Arevalo-Martin A., Ortiz S., Vela J.M., and Guaza C. Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10. Neurosci. Lett. 324 (2002) 237-241
56. Montine T.J., Milatovic D., Gupta R.C., Valyi-Nagy T., Morrow J.D., and Breyer R.M. Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J. Neurochem. 83 (2002) 463-470
57. Nakayama M., Uchimura K., Zhu R.L., Nagayama T., Rose M.E., Stetler R.A., Isakson P.C., Chen J., and Graham S.H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10954-10959
58. Ni L., Acevedo G., Muralidharan B., Padala N., To J., and Jonakait G.M. Toll-like receptor ligands and CD154 stimulate microglia to produce a factor(s) that promotes excess cholinergic differentiation in the developing rat basal forebrain: implications for neurodevelopmental disorders. Pediatr. Res. 61 (2007) 15-20
59. Nogawa S., Zhang F., Ross M.E., and Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17 (1997) 2746-2755
60. Norel X., Walch L., Labat C., Gascard J.P., Dulmet E., and Brink C. Prostanoid receptors involved in the relaxation of human bronchial preparations. Br. J Pharmacol. 126 (1999) 867-872
61. Pasinetti G.M., and Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neurosci. 87 (1998) 319-324
62. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr. Opin. Neurobiol. 12 (2002) 115-118
63. Plesnila N., Zhu C., Culmsee C., Groger M., Moskowitz M.A., and Blomgren K. Nuclear translocation of apoptosis-inducing factor after focal cerebral ischemia. J Cereb. Blood Flow Metab. 24 (2004) 458-466
64. Pompl P.N., Ho L., Bianchi M., McManus T., Qin W., and Pasinetti G.M. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 17 (2003) 725-727
65. Prasad K.N., Hovland A.R., La Rosa F.G., and Hovland P.G. Prostaglandins as putative neurotoxins in Alzheimer's disease. Proc. Soc. Exp. Biol. Med. 219 (1998) 120-125
66. Randall C.L., Anton R.F., Becker H.C., and White N.M. Role of prostaglandins in alcohol teratogenesis. Ann. N. Y. Acad. Sci. 562 (1989) 178-182
67. Refsnes M., Dajani O.F., Sandnes D., Thoresen G.H., Rottingen J.A., Iversen J.G., and Christoffersen T. On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase C. J. Cell. Physiol. 164 (1995) 465-473
68. Rozenfeld C., Martinez R., Figueiredo R.T., Bozza M.T., Lima F.R., Pires A.L., Silva P.M., Bonomo A., Lannes-Vieira J., De Souza W., and Moura-Neto V. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect. Immun. 71 (2003) 2047-2057
69. Saleem S., Li R.C., Wei G., and Dore S. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J. Neurosci. Res. 85 (2007) 2433-2440
70. Scali C., Prosperi C., Vannucchi M.G., Pepeu G., and Casamenti F. Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur. J. Neurosci. 12 (2000) 1900-1912
71. Skold M., Cullheim S., Hammarberg H., Piehl F., Suneson A., Lake S., Sjogren A., Walum E., and Risling M. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur. J. Neurosci. 12 (2000) 3675-3686
72. Slagsvold H.H., Rosseland C.M., Jacobs C., Khuong E., Kristoffersen N., Gaarder M., Fallgren A.B., Huitfeldt H.S., and Paulsen R.E. High molecular weight DNA fragments are processed by caspase sensitive or caspase independent pathways in cultures of cerebellar granule neurons. Brain Res. 984 (2003) 111-121
73. Slawik H., Volk B., Fiebich B., and Hull M. Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum. Neurochem. Int. 45 (2004) 653-660
74. Slemmer J.E., Zhu C., Landshamer S., Trabold R., Grohm J., Ardeshiri A., Wagner E., Sweeney M.I., Blomgren K., Culmsee C., Weber J.T., and Plesnila N. Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury. Am. J. Pathol. 173 (2008) 1795-1805
75. Smith S.E., Li J., Garbett K., Mirnics K., and Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27 (2007) 10695-10702
76. Takadera T., Yumoto H., Tozuka Y., and Ohyashiki T. Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci. Lett. 317 (2002) 61-64
77. Takadera T., Shiraishi Y., and Ohyashiki T. Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons. Neurochem. Int. 45 (2004) 713-719
78. Teismann P., Vila M., Choi D.K., Tieu K., Wu D.C., Jackson-Lewis V., and Przedborski S. COX-2 and neurodegeneration in Parkinson's disease. Ann. N. Y. Acad. Sci. 991 (2003) 272-277
79. Thorburn G.D. The placenta, PGE2 and parturition. Early Hum. Dev. 29 (1992) 63-73
80. Vassiliou E., Sharma V., Jing H., Sheibanie F., and Ganea D. Prostaglandin E2 promotes the survival of bone marrow-derived dendritic cells. J. Immunol. 173 (2004) 6955-6964
81. Wang, Y., Dawson V.L., Dawson T.M. in press. Poly (ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp. Neurol. doi:10.1016/j.expneurol.2009.03.020.
82. White K.E., Ding Q., Moore B.B., Peters-Golden M., Ware L.B., Matthay M.A., and Olman M.A. Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors. J. Immunol. 180 (2008) 637-646
83. Williams A., Van Dam A.M., Ritchie D., Eikelenboom P., and Fraser H. Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 754 (1997) 171-180
84. Yavin E., Goldin E., Magal E., Tomer A., and Harel S. Ischemia stress and arachidonic acid metabolites in the fetal brain. Ann. N. Y. Acad. Sci. 559 (1989) 248-258
85. Zhang L., Jiang L., Sun Q., Peng T., Lou K., Liu N., and Leng J. Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling. Mol. Cell. Biochem. 305 (2007) 19-26
86. Zhu C., Qiu L., Wang X., Hallin U., Cande C., Kroemer G., Hagberg H., and Blomgren K. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J. Neurochem. 86 (2003) 306-317
87. Zhu C., Wang X., Huang Z., Qiu L., Xu F., Vahsen N., Nilsson M., Eriksson P.S., Hagberg H., Culmsee C., Plesnila N., Kroemer G., and Blomgren K. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 14 (2007) 775-784